Oldest pages

Jump to navigation Jump to search

Showing below up to 50 results in range #4,401 to #4,450.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Zito PM, et al. () cited as Ref 603 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  2. Robinson GW, et al. J. Clin. Oncol. (2015) cited as Ref 604 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  3. Gajjar A, et al. Clin. Cancer Res. (2013) cited as Ref 605 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  4. Berlin J, et al. Clin. Cancer Res. (2013) cited as Ref 606 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  5. Catenacci DV, et al. J. Clin. Oncol. (2015) cited as Ref 607 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  6. Italiano A, et al. Ann. Oncol. (2013) cited as Ref 608 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  7. Houot R, et al. Ann. Oncol. (2016) cited as Ref 609 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  8. Kaye SB, et al. Clin. Cancer Res. (2012) cited as Ref 610 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  9. Pan S, et al. ACS Med. Chem. Lett. (2010) cited as Ref 611 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  10. Kieran MW, et al. Neuro Oncol. (2017) cited as Ref 612 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  11. Magnani L, et al. Proc. Natl Acad. Sci. USA (2013) cited as Ref 613 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  12. Cortes JE, et al. Am. J. Hematol. (2018) cited as Ref 614 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  13. Cortes JE, et al. Leukemia (2019) cited as Ref 615 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  14. List A, et al. Leukemia (2003) cited as Ref 616 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  15. Lauth M, et al. Proc. Natl Acad. Sci. USA (2007) cited as Ref 617 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  16. Pohl SG, et al. Oncogenesis (2017) cited as Ref 618 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  17. Kraggerud SM, et al. Endocr. Rev. (2013) cited as Ref 619 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  18. Fu L, et al. Gut (2011) cited as Ref 620 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  19. Hua F, et al. Gastroenterology (2019) cited as Ref 621 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  20. Pal SK, et al. Eur. Urol. (2019) cited as Ref 622 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  21. Lin W, et al. Biomed. Res. Int. (2019) cited as Ref 623 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  22. Le PN, et al. Pharmacol. Ther. (2015) cited as Ref 624 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  23. Jimeno A, et al. Clin. Cancer Res. (2013) cited as Ref 625 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  24. Cortes JE, et al. J. Clin. Oncol. (2015) cited as Ref 626 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  25. Konopleva M, et al. Cancer Discov. (2016) cited as Ref 627 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  26. Saygin C, et al. Cell Stem Cell (2019) cited as Ref 628 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  27. Cashen A, et al. Biol. Blood Marrow Transplant. (2008) cited as Ref 629 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  28. Uy GL, et al. Blood (2012) cited as Ref 630 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  29. Cooper TM, et al. Pediatr. Blood Cancer (2017) cited as Ref 631 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  30. Galsky MD, et al. Clin. Cancer Res. (2014) cited as Ref 632 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  31. Hainsworth JD, et al. Target Oncol. (2016) cited as Ref 633 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  32. Salgia R, et al. Lung Cancer (2017) cited as Ref 634 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  33. Sakamuri D, et al. Mol. Cancer Ther. (2018) cited as Ref 635 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  34. Meindl-Beinker NM, et al. BMC Cancer (2019) cited as Ref 636 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  35. Cortese I, et al. N. Engl. J. Med. (2019) cited as Ref 637 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:10, 20 May 2020)
  36. Migden MR, et al. N. Engl. J. Med. (2018) cited as Ref 638 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:11, 20 May 2020)
  37. Motzer RJ, et al. N. Engl. J. Med. (2019) cited as Ref 639 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:11, 20 May 2020)
  38. Fujiwara Y, et al. Cancer Sci. (2019) cited as Ref 640 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:11, 20 May 2020)
  39. Sullivan RJ, et al. Nat. Med. (2019) cited as Ref 641 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:11, 20 May 2020)
  40. Hodi FS, et al. N. Engl. J. Med. (2010) cited as Ref 642 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:11, 20 May 2020)
  41. Nandy SB, et al. Prog. Mol. Biol. Transl. Sci. (2017) cited as Ref 643 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:11, 20 May 2020)
  42. Rich JN, et al. Medicine (2016) cited as Ref 644 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:11, 20 May 2020)
  43. Prieto-Vila M, et al. Int. J. Mol. Sci. (2017) cited as Ref 645 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:11, 20 May 2020)
  44. Zhao J, et al. Pharmacol. Ther. (2016) cited as Ref 646 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:11, 20 May 2020)
  45. Chang L, et al. Oncotarget (2016) cited as Ref 647 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:11, 20 May 2020)
  46. Liu B, et al. Am. J. Cancer Res. (2019) cited as Ref 648 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:11, 20 May 2020)
  47. Bao B, et al. Current protocols in pharmacology Chapter 14:Unit14.25 (2013) cited as Ref 649 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:11, 20 May 2020)
  48. Shultz LD, et al. Nat. Rev. Immunol. (2012) cited as Ref 650 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:11, 20 May 2020)
  49. Plaks V, et al. Cell Stem Cell (2015) cited as Ref 651 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:11, 20 May 2020)
  50. Takeishi S, et al. Cancer Sci. (2016) cited as Ref 652 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:11, 20 May 2020)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)